CL
The startup develops AI-based software that facilitates the design of novel organic molecules and scaffolds through in silico reaction planning and evaluation. This technology enables medical research centers to efficiently create new drugs, improving the quality and success rate of drug development.
Updated 3 months ago
Funding
$430K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops AI-based software that facilitates the design of novel organic molecules and scaffolds through in silico reaction planning and evaluation. This technology enables medical research centers to efficiently create new drugs, improving the quality and success rate of drug development.